These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12485924)

  • 1. Possible signaling by glutathione and its novel analogue through potent stimulation of fontocortical G proteins in normal aging and in Alzheimer's disease.
    Karelson E; Mahlapuu R; Zilmer M; Soomets U; Bogdanovic N; Langel U
    Ann N Y Acad Sci; 2002 Nov; 973():537-40. PubMed ID: 12485924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain.
    Mahlapuu R; Viht K; Balaspiri L; Bogdanovic N; Saar K; Soomets U; Land T; Zilmer M; Karelson E; Langel U
    Brain Res Mol Brain Res; 2003 Sep; 117(1):73-82. PubMed ID: 14499483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine muscarinic M2 receptor stimulated [35S]GTP gamma S binding shows regional selective changes in Alzheimer's disease postmortem brain.
    Cowburn RF; Wiehager B; Ravid R; Winblad B
    Neurodegeneration; 1996 Mar; 5(1):19-26. PubMed ID: 8731378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms.
    Karelson E; Fernaeus S; Reis K; Bogdanovic N; Land T
    J Neurosci Res; 2005 Feb; 79(3):368-74. PubMed ID: 15614786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17beta-Oestradiol stimulation of G-proteins in aged and Alzheimer's human brain: comparison with phytoestrogens.
    Jefremov V; Rakitin A; Mahlapuu R; Zilmer K; Bogdanovic N; Zilmer M; Karelson E
    J Neuroendocrinol; 2008 May; 20(5):587-96. PubMed ID: 18363809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of stimulatory effect of guanosine triphosphate on [(35)S]GTPgammaS binding correlates with Alzheimer's disease neurofibrillary pathology in entorhinal cortex and CA1 hippocampal subfield.
    García-Jiménez A; Cowburn RF; Ohm TG; Lasn H; Winblad B; Bogdanovic N; Fastbom J
    J Neurosci Res; 2002 Feb; 67(3):388-98. PubMed ID: 11813244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of methionine-722 in the stimulation of human brain G-proteins and neurotoxicity induced by London familial Alzheimer's disease (FAD) mutated V717G-APP(714-723).
    Reis K; Zharkovsky A; Bogdanovic N; Karelson E; Land T
    Neuroscience; 2007 Jan; 144(2):571-8. PubMed ID: 17101228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease.
    Albasanz JL; Perez S; Barrachina M; Ferrer I; Martín M
    Brain Pathol; 2008 Apr; 18(2):211-9. PubMed ID: 18241242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells.
    Gardner B; Hall DA; Strange PG
    Br J Pharmacol; 1996 Jul; 118(6):1544-50. PubMed ID: 8832084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of guanine-nucleotide-binding protein involvement and regulation of cyclic AMP metabolism in interleukin 1 signal transduction.
    Ray K; Thompson N; Kennard N; Rollins P; Grenfell S; Witham S; Smithers N; Solari R
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):59-67. PubMed ID: 1311561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease.
    Lumbreras M; Baamonde C; Martínez-Cué C; Lubec G; Cairns N; Sallés J; Dierssen M; Flórez J
    Amino Acids; 2006 Nov; 31(4):449-56. PubMed ID: 16583316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain.
    O'Neill C; Wiehager B; Fowler CJ; Ravid R; Winblad B; Cowburn RF
    Brain Res; 1994 Feb; 636(2):193-201. PubMed ID: 8012802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenylyl cyclase activity in postmortem human brain: evidence of altered G protein mediation in Alzheimer's disease.
    Cowburn RF; O'Neill C; Ravid R; Alafuzoff I; Winblad B; Fowler CJ
    J Neurochem; 1992 Apr; 58(4):1409-19. PubMed ID: 1548475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional activation defect of a human Gsalpha mutant.
    Iiri T; Farfel Z; Bourne HR
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5656-61. PubMed ID: 9159128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of metabotropic glutamate receptors in Gi- and Gs-dependent modulation of adenylate cyclase activity induced by a novel cognition enhancer NS-105 in rat brain.
    Oka M; Itoh Y; Shimidzu T; Ukai Y; Yoshikuni Y; Kimura K
    Brain Res; 1997 Apr; 754(1-2):121-30. PubMed ID: 9134967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired G-protein-stimulated adenylyl cyclase activity in Alzheimer's disease brain is not accompanied by reduced cyclic-AMP-dependent protein kinase A activity.
    Bonkale WL; Fastbom J; Wiehager B; Ravid R; Winblad B; Cowburn RF
    Brain Res; 1996 Oct; 737(1-2):155-61. PubMed ID: 8930361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein coupled signal transduction systems in the Alzheimer's disease brain.
    O'Neill C; Fowler CJ; Winblad B; Cowburn RF
    Biochem Soc Trans; 1994 Feb; 22(1):167-71. PubMed ID: 8206216
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple cyclic AMP receptors are linked to adenylyl cyclase in Dictyostelium.
    Pupillo M; Insall R; Pitt GS; Devreotes PN
    Mol Biol Cell; 1992 Nov; 3(11):1229-34. PubMed ID: 1333842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.
    Kelly MP
    Cell Signal; 2018 Jan; 42():281-291. PubMed ID: 29175000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease.
    Venkateshappa C; Harish G; Mahadevan A; Srinivas Bharath MM; Shankar SK
    Neurochem Res; 2012 Aug; 37(8):1601-14. PubMed ID: 22461064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.